MULLEN JAMES C 4
4 · Editas Medicine, Inc. · Filed Oct 20, 2021
Insider Transaction Report
Form 4
MULLEN JAMES C
Director
Transactions
- Sale
Common Stock
2021-10-18$38.03/sh−13,805$525,033→ 57,673 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on March 4, 2021, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 30, 2021. The sale does not represent a discretionary trade by the Reporting Person.